Stocks and Investing Stocks and Investing
Thu, May 30, 2019
Wed, May 29, 2019
Tue, May 28, 2019
Fri, May 24, 2019

Brian Abrahams Downgraded (BCRX) to Hold and Decreased Target to $4.5 on, May 24th, 2019


Published on 2024-10-26 13:54:53 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Downgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Hold and Decreased Target from $16 to $4.5 on, May 24th, 2019.

Brian has made no other calls on BCRX in the last 4 months.



There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, all agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Increased Target to $8 on, Tuesday, April 2nd, 2019
Contributing Sources